715.83K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Drug Manufacturers - General
Industry

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement.

Similar securities

Based on sector and market capitalization

Report issue